
It's not just Wiz - Q1 was full of M&A for early-stage startups as well.
Chart below looks at deals in Q1 over the last 5 years.
Here's the data from US startups using Carta:
Most M&A transactions in a single quarter for companies that had yet to raise priced funding: 48 deals
Most M&A transactions in a single quarter for Seed + Series A companies: 107 deals
Highest quarter ever for M&A on Carta: 180 deals
So best Q1 ever and best quarter ever period in terms of deal count.
Animal spirits do seem to be coming back.
Now there are a few things we don't know, unfortunately. We don't know whether these deals all resulted in big payouts for the founders and employees (my instinct is many were acquihires or small wins at the early stages).
We don't know how many of them cleared the last valuation price (or cleared any liquidation preferences that may have existed, although those are rare in the early stages overall).
This activity is needed but obviously doesn't go very far in replacing liquidity from IPOs - fingers crossed we see a few more of those now that Coreweave is out.
Here's to Q2!
#startups #founders #mergers #acquisitions #startupdeals
DISCLOSURE: This communication is on behalf of eShares, Inc. dba Carta, Inc. ("Carta"). This communication is for informational purposes only, and contains general information only. Carta is not, by means of this communication, rendering accounting, business, financial, investment, legal, tax, or other professional advice or services. This publication is not a substitute for such professional advice or services nor should it be used as a basis for any decision or action that may affect your business or interests. Before making any decision or taking any action that may affect your business or interests, you should consult a qualified professional advisor. This communication is not intended as a recommendation, offer or solicitation for the purchase or sale of any security. Carta does not assume any liability for reliance on the information provided herein. © 2026 Carta. All rights reserved. Reproduction prohibited.



